XML 31 R17.htm IDEA: XBRL DOCUMENT v3.23.1
BASIC AND DILUTED NET LOSS PER SHARE
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
BASIC AND DILUTED NET LOSS PER SHARE

NOTE 11 - BASIC AND DILUTED NET LOSS PER SHARE

 

The basic and diluted net loss per share and weighted average number of shares of common stock used in the calculation of basic and diluted net loss per share were presented in the consolidated statements of comprehensive loss for the years ended December 31, 2022 and 2021.

 

Due to the net loss to common stockholders in each of the periods presented above, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. As of December 31, 2022 and 2021, potentially dilutive securities excluded from the diluted loss per share calculation are as follows:

 

   For the Years Ended December 31, 
   2022   2021 
         
Series A and B warrants 2013 and 2016   183    2,953 
Warrant to underwriters 12.2019   138,307    175,889 
Series A and B warrants 10.2022   2,044,990    - 
Warrant to underwriters 10.2022   51,125    - 
Outstanding options to purchase common stock   1,507,137    997,148 

 

 

MICROBOT MEDICAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

(Except share and per share data)